Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine

NCT02969876 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02969876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02969876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
August 24, 2017
Completion date
August 6, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depression, unipolar, depressive disorder, major depression